Free Trial

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Sees Large Increase in Short Interest

Biodexa Pharmaceuticals logo with Medical background

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX - Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 290,200 shares, a growth of 323.6% from the March 31st total of 68,500 shares. Currently, 0.8% of the shares of the stock are sold short. Based on an average daily volume of 1,820,000 shares, the days-to-cover ratio is presently 0.2 days.

Biodexa Pharmaceuticals Trading Up 1.1 %

Biodexa Pharmaceuticals stock traded up $0.02 during mid-day trading on Friday, hitting $1.43. 12,908 shares of the company traded hands, compared to its average volume of 583,519. Biodexa Pharmaceuticals has a one year low of $1.14 and a one year high of $74.00. The stock has a fifty day moving average price of $1.92 and a 200-day moving average price of $3.79.

Biodexa Pharmaceuticals Company Profile

(Get Free Report)

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.

Further Reading

Should You Invest $1,000 in Biodexa Pharmaceuticals Right Now?

Before you consider Biodexa Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Biodexa Pharmaceuticals wasn't on the list.

While Biodexa Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines